262 HUMANE TREATMENT OF ANEVIALS USED IN RESEARCH 
And control must be designed so as not to impede experimental work 
and medical science, and the advances that you want. 
I mean there are many things that seem so bad. Crushed limbs 
seem terrible. But the war was terrible, too. And the people who died 
of that syndrome were a very real problem during the war. Radiation 
and fallout come in, and they are very real problems today. There are 
many things that we have got to study that are not happy or good for 
the animals. But they are certainly very bad for man. 
Mr. Roberts. You think that there might be some consideration 
given to the repetition of experiments in animals — I mean if you are 
doing research in one section of the institution, that can be carried 
over to another part of the institution — do you think there might 
be some way in which, through a reporting system, or some other 
type of system, exchange of information could be had, where we could 
minimize some of these experiments without endangering research ? 
Dr. Taussig. That is really very difficult. Particularly when you 
think of thalidomide — how hard it is to reproduce this in animals. 
Some company would say, “Yes, we have done that, and there is no 
harm,” and the next one would say, “Yes, we have done it slightly 
differently, have different results.” Results should be checked. 
When I was over in Portugal, they told me 8 months after the date 
of the publicity, thalidomide was probably the cause of this condition, 
the condition dropped to almost zero. It showed it was a very potent 
cause indeed. 
Mr. Roberts. Thank you very much. 
Are there any other witnesses who cannot attend the meeting to- 
morrow ? 
Mrs. Twyne, will you come around ? 
STATEMENT OF MRS. PAUL M. TWYNE, PRESIDENT OE THE 
VIRGINIA FEDERATION OF HUMANE SOCIETIES 
Mrs. Twyne. I am Mrs. Paul M. Twyne, president of the Virginia 
Federation of Humane Societies. I am also an alternate on the Ani- 
mal Allocation Board for the Government of the District of Columbia. 
The function of this Board is to advise the Commissioners in making 
policy determinations regarding the use of impounded animals for 
medical research and instruction, and to assist the Director, Depart- 
ment of Public Health, in developing standards and criteria for licens- 
ing institutions, and to assist the Director, Department of Public 
Health, in developing standards and criteria for licensing institutions 
that desire to obtain such animals. 
That became effective when the pound seizure law was approved by 
the Commissioners of the District of Columbia — that an Allocation 
Board would decide the standards and work with the various officials. 
And it has helped some, I think, in the District. 
It is one of the controls that one of the doctors mentioned earlier. 
I appreciate the opportunity to appear before your committee and 
ask for your approval of bills PI.R. 1937 and H.R. 3556 — the humane 
treatment of laboratory animals. 
One result of the accelerated growth in medical research has been 
the development of a huge industry throughout the Nation in the pro- 
curing of animals and selling them to the laboratories. There are two 
